Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...

SAS Viya Essentials rapidly deploys select SAS Viya products using SAS Managed Cloud Services Thursday, 20 November 2025 - SAS, a global ...

The eighth edition of the initiative has unveiled the 12 projects partaking in its Impact Lab, focusing on stories that ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

The documentary special "Living Proof," produced by Sheryl Lee Ralph, will premiere on Hulu on Dec. 1 in honor of World AIDS ...

Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...

Economists warned that restoring confidence in government will be difficult, as the recent Cabinet shakeup could deepen uncertainty unless it comes with meaningful reforms and clear accountability.

The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...

The Name on the Wall” unspools the short life of a French resistance foot soldier, whose ordinary bravery contrasted with the ...

Initial results of ongoing investigator-initiated proof-of-concept trial demonstrate crofelemer can potentially extend the lives of infants born with intestinal failure due to microvillus inclusion ...